Anteris Technologies Global (AVR) & Its Rivals Head to Head Analysis

Anteris Technologies Global (NASDAQ:AVR) is one of 142 public companies in the “MED INSTRUMENTS” industry, but how does it compare to its competitors? We will compare Anteris Technologies Global to related companies based on the strength of its analyst recommendations, dividends, institutional ownership, valuation, risk, profitability and earnings.

Profitability

This table compares Anteris Technologies Global and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	N/A	N/A	N/A
Anteris Technologies Global Competitors	-182.36%	-90.09%	-20.54%

Institutional & Insider Ownership

54.1% of shares of all “MED INSTRUMENTS” companies are owned by institutional investors. 4.0% of Anteris Technologies Global shares are owned by insiders. Comparatively, 14.3% of shares of all “MED INSTRUMENTS” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Anteris Technologies Global and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1	0	4	0	2.60
Anteris Technologies Global Competitors	1167	3796	7132	266	2.53

Anteris Technologies Global currently has a consensus target price of $16.50, suggesting a potential upside of 314.57%. As a group, “MED INSTRUMENTS” companies have a potential upside of 20.45%. Given Anteris Technologies Global’s stronger consensus rating and higher possible upside, equities analysts clearly believe Anteris Technologies Global is more favorable than its competitors.

Earnings and Valuation

This table compares Anteris Technologies Global and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Anteris Technologies Global	$2.70 million	-$76.29 million	-3.34
Anteris Technologies Global Competitors	$1.75 billion	$198.05 million	6.08

Anteris Technologies Global’s competitors have higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.